Illustrative image – not actual.Nectar Lifesciences is planning to invest Rs 600 crore to set up a drug facility at Lalru in Punjab.
The proposed plant with a production capacity of 1,000 million tpa is likely to be spread over 148 acre. The plant is expected to be completed by 2011 and manufacture active pharmaceutical ingredients and formulations for the identified segments of oncology, cardiovascular, anti-diabetics and anti-HIV.
